# A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17

> **NCT00951535** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Cancer Trials Ireland** · enrollment: 251 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** questionnaire administration
- **PROCEDURE:** quality-of-life assessment
- **RADIATION:** image-guided radiation therapy
- **RADIATION:** intensity-modulated radiation therapy
- **RADIATION:** radiation therapy treatment planning/simulation

## Key facts

- **NCT ID:** NCT00951535
- **Lead sponsor:** Cancer Trials Ireland
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2009-07-20
- **Primary completion:** 2026-05
- **Final completion:** 2026-06
- **Target enrollment:** 251 (ACTUAL)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00951535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00951535, "A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00951535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*